In the sarcoma field xenograft models expressing mutant TP53 in pleomorphic rhabdomyosarcomas, the tumor profile was even more aggressive and with greater metastatic potential than p53 null or p53 wild-type tumors. This evidence concerns the gene TP53 and sarcoma.